QL Biopharm Announces Abstract on Novel Ultra Long-acting GLP-1RA to be Presented at EASD Annual Meeting 2024 ...Middle East

PR Newswire - Economy
– Abstract on data from a two-part phase 1c, multiple ascending dose study accepted for oral presentation – – New data highlighting the Company's lead drug candidate ZT002 for obesity – BEIJING, Sept. 3, 2024 /PRNewswire/ -- Beijing QL Biopharmaceutical Co., Ltd. ("QL Biopharm"), a...

Hence then, the article about ql biopharm announces abstract on novel ultra long acting glp 1ra to be presented at easd annual meeting 2024 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( QL Biopharm Announces Abstract on Novel Ultra Long-acting GLP-1RA to be Presented at EASD Annual Meeting 2024 )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy


Latest News